artenimol has been researched along with Blood Poisoning in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Li, Y; Liu, F; Liu, J; Liu, Y; Sun, Z; Xiang, H | 1 |
| Allen, TD; Cheng, Z; Li, L; Liu, J; Liu, Q; Pan, S; Qi, R; Xu, D; Zhang, W; Zhou, X | 1 |
2 other study(ies) available for artenimol and Blood Poisoning
| Article | Year |
|---|---|
Dihydroartemisinin protects blood-brain barrier permeability during sepsis by inhibiting the transcription factor SNAI1.
Topics: Animals; Artemisinins; Blood-Brain Barrier; Endothelial Cells; Humans; Mice; Occludin; Permeability; Sepsis; Snail Family Transcription Factors; Transcription Factors; Tumor Necrosis Factor-alpha | 2022 |
Dihydroartemisinin ameliorates sepsis-induced hyperpermeability of glomerular endothelium via up-regulation of occludin expression.
Topics: Acute Kidney Injury; Animals; Apoptosis; Artemisinins; Cell Survival; Disease Models, Animal; Endothelial Cells; Endothelium; Humans; Kidney Glomerulus; Lipopolysaccharides; Mice, Inbred C57BL; Occludin; Permeability; Sepsis; Tumor Necrosis Factor-alpha; Up-Regulation | 2018 |